Price
Financials
Standalone, Rs crore| Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 14.15 | 19.24 | 22.08 | 34.51 | 25.61 | 30.73 | 29.83 | 35.07 | 28.74 | 33.54 | 30.14 | 33.32 |
| Expenses | 12.45 | 18.36 | 21.15 | 33.46 | 23.97 | 29.76 | 29.39 | 33.67 | 27.11 | 31.50 | 27.07 | 31.79 |
| Operating Profit | 1.70 | 0.88 | 0.93 | 1.05 | 1.64 | 0.97 | 0.44 | 1.40 | 1.63 | 2.04 | 3.07 | 1.53 |
| OPM % | 12.01% | 4.57% | 4.21% | 3.04% | 6.40% | 3.16% | 1.48% | 3.99% | 5.67% | 6.08% | 10.19% | 4.59% |
| Other Income | 0.02 | 0.40 | 0.71 | 0.24 | 0.00 | 0.92 | 1.14 | 0.02 | 0.00 | 0.00 | -3.98 | 0.02 |
| Interest | 0.69 | 0.70 | 0.68 | 0.79 | 0.71 | 0.67 | 0.66 | 0.86 | 0.83 | 0.79 | 0.74 | 0.93 |
| Depreciation | 0.23 | 0.23 | 0.19 | 0.20 | 0.20 | 0.26 | 0.19 | 0.20 | 0.19 | 0.19 | 0.21 | 0.19 |
| Profit before tax | 0.80 | 0.35 | 0.77 | 0.30 | 0.73 | 0.96 | 0.73 | 0.36 | 0.61 | 1.06 | -1.86 | 0.43 |
| Tax % | 25.00% | 25.71% | 38.96% | 10.00% | 19.18% | 20.83% | 43.84% | 25.00% | 24.59% | 26.42% | -23.12% | 23.26% |
| Net Profit | 0.60 | 0.27 | 0.46 | 0.27 | 0.58 | 0.76 | 0.42 | 0.28 | 0.46 | 0.77 | -1.43 | 0.33 |
| EPS in Rs | 0.76 | 0.34 | 0.58 | 0.34 | 0.74 | 0.97 | 0.53 | 0.36 | 0.58 | 0.98 | -1.82 | 0.42 |
| Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 31 | 30 | 19 | 30 | 28 | 29 | 51 | 76 | 70 | 121 | 128 | 126 |
| Expenses | 31 | 28 | 22 | 28 | 26 | 26 | 48 | 72 | 66 | 117 | 119 | 117 |
| Operating Profit | -1 | 2 | -3 | 2 | 2 | 3 | 3 | 4 | 4 | 4 | 8 | 8 |
| OPM % | -2.8% | 7% | -14% | 8% | 7% | 10% | 7% | 5% | 6% | 3.4% | 6% | 7% |
| Other Income | 3 | 0 | 5 | 0 | 1 | 0 | 0 | 1 | 1 | 2 | -4 | -4 |
| Interest | 1 | 2 | 1 | 1 | 1 | 1 | 1 | 2 | 3 | 3 | 3 | 3 |
| Depreciation | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
| Profit before tax | 0 | 0 | 0 | 1 | 1 | 1 | 1 | 2 | 2 | 3 | 0 | 0 |
| Tax % | 35% | 56% | -22% | 24% | 54% | 24% | 26% | 25% | 30% | 25% | 56% | |
| Net Profit | 0 | 0 | 1 | 1 | 0 | 1 | 1 | 1 | 2 | 2 | 0 | 0 |
| EPS in Rs | 0.22 | 0.24 | 0.69 | 0.76 | 0.47 | 0.92 | 1.30 | 1.72 | 1.93 | 2.58 | 0.10 | 0.16 |
| Dividend Payout % | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| 10 Years | 5 Years | 3 Years | TTM | 1 Year | Last Year | |
|---|---|---|---|---|---|---|
| Compounded Sales Growth | 15% | 35% | 19% | 4% | ||
| Compounded Profit Growth | 38% | 42% | 46% | 107% | ||
| Stock Price CAGR | 15% | 21% | 4% | -15% | ||
| Return on Equity | 10% | 13% | 16% | 24% |
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 8 | 8 | 8 | 8 | 8 | 8 | 8 | 8 | 8 | 8 | 8 | 8 |
| Reserves | 1 | 1 | 2 | 2 | 3 | 3 | 4 | 5 | 6 | 8 | 10 | 10 |
| Borrowings | 8 | 8 | 11 | 16 | 15 | 14 | 13 | 12 | 19 | 26 | 33 | 31 |
| Other Liabilities | 8 | 8 | 8 | 10 | 11 | 14 | 21 | 24 | 24 | 23 | 26 | 23 |
| Total Liabilities | 26 | 25 | 29 | 35 | 36 | 38 | 46 | 49 | 57 | 65 | 76 | 72 |
| Fixed Assets | 8 | 7 | 7 | 6 | 6 | 11 | 10 | 10 | 10 | 9 | 8 | 8 |
| CWIP | 0 | 0 | 0 | 2 | 4 | 0 | 0 | 1 | 1 | 1 | 1 | 0 |
| Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Assets | 18 | 18 | 22 | 27 | 26 | 28 | 36 | 39 | 46 | 55 | 68 | 64 |
| Total Assets | 26 | 25 | 29 | 35 | 36 | 38 | 46 | 49 | 57 | 65 | 76 | 72 |
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash from Operating Activity | 1 | 1 | -1 | -5 | 4 | 2 | -1 | 2 | -0 | 2 | -7 | 5 |
| Cash from Investing Activity | -0 | 0 | -0 | 2 | -2 | 1 | 1 | 4 | -1 | 1 | 2 | -0 |
| Cash from Financing Activity | -0 | -1 | 2 | 2 | -2 | -3 | -1 | -5 | 2 | -2 | 5 | -8 |
| Net Cash Flow | 0 | -0 | -0 | 0 | 0 | 0 | 0 | 1 | 0 | 1 | 0 | -3 |
| Free Cash Flow | 0 | 1 | -2 | -7 | 2 | 2 | -1 | 2 | -2 | 2 | -7 | 4 |
| CFO/OP | 28% | -146% | -50% | 168% | 184% | 157% | -11% | 78% | 2% | 60% | -143% | 59% |
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 66 | 99 | 146 | 233 | 134 | 157 | 147 | 112 | 34 | 43 | 39 | 63 |
| Inventory Days | 143 | 70 | 139 | 217 | 171 | 256 | 409 | 140 | 109 | 168 | 121 | 102 |
| Days Payable | 132 | 100 | 122 | 177 | 123 | 219 | 280 | 86 | 42 | 96 | 56 | 41 |
| Cash Conversion Cycle | 77 | 69 | 164 | 273 | 182 | 194 | 277 | 166 | 101 | 116 | 104 | 123 |
| Working Capital Days | 32 | 69 | 114 | 214 | 108 | 104 | 114 | 37 | 1 | 10 | 36 | 32 |
| ROCE % | 10% | 10% | 10% | 6% | 9% | 9% | 8% | 10% | 13% | 12% | 12% | 15% |
| Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Promoters | 48.03% | 48.03% | 48.03% | 48.03% | 48.03% | 48.03% | 48.03% | 48.03% | 48.03% | 48.03% | 48.03% | 48.03% |
| FIIs | 0.25% | 0.25% | 0.25% | 0.25% | 0.25% | 0.25% | 0.25% | 0.25% | 0.25% | 0.25% | 0.25% | 0.25% |
| Public | 51.72% | 51.72% | 51.73% | 51.72% | 51.72% | 51.71% | 51.71% | 51.71% | 51.72% | 51.71% | 51.72% | 51.72% |
| No. of Shareholders | 3,490 | 3,584 | 3,622 | 3,616 | 3,813 | 4,005 | 4,007 | 4,002 | 3,982 | 3,952 | 3,954 | 3,888 |
Fundamentals
Market Cap₹ 35.9 Cr.
Current Price₹ 45.7
Stock P/E8.51
Book Value₹ 22.4
ROCE15.0 %
ROE23.8 %
Dividend Yield0.00 %
Face Value₹ 10.0
Compounded Sales Growth (TTM)4%
Compounded Profit Growth (TTM)107%
Standalone figures.
Valuation
Market capRs 37 Cr
Enterprise valueRs 66 Cr
P/E (TTM)283.76x
Price to book2.10x
Price to sales0.29x
EV / EBITDA15.40x
EV / EBIT18.80x
EV / sales0.53x
Price to cash flow7.88x
Earnings yield0.35%
P/E, 3-year average145.25x
P/B, 3-year average2.35x
P/E, 5-year average95.78x
P/B, 5-year average2.19x
Profitability
Operating margin (excl. other income)6.38%
Operating margin (incl. other income)3.28%
EBITDA margin3.43%
Pre-tax margin0.19%
Net profit margin0.10%
Net margin, latest quarter0.99%
ROE0.46%
ROCE6.80%
ROA0.11%
ROE, 3-year average7.70%
ROCE, 3-year average10.54%
ROA, 3-year average1.83%
ROE, 5-year average8.34%
ROCE, 5-year average10.94%
ROA, 5-year average2.04%
ROIC (approx.)3.28%
Tax rate56.25%
Other income / net worth-22.50%
Growth
Sales growth (latest year)5.64%
Profit growth (latest year)-96.06%
Sales CAGR, 3 years18.73%
Sales CAGR, 5 years34.83%
Profit CAGR, 3 years-61.01%
Profit CAGR, 5 years-35.56%
Sales growth QoQ10.55%
Sales growth YoY (latest quarter)-4.99%
Profit growth YoY (latest quarter)17.86%
Per share
EPS (TTM)Rs 0.17
EPS (latest year)Rs 0.10
EPS (latest quarter)Rs 0.42
EPS, 3-year averageRs 1.54
EPS, 5-year averageRs 1.53
Book value per shareRs 22.38
Sales per shareRs 159.86
Cash flow per shareRs 5.95
Free cash flow per shareRs 5.09
Efficiency
Asset turnover1.77x
Fixed asset turnover15.16x
Inventory turnover3.66x
Inventory days100 days
Debtor days63 days
Debtors turnover5.82x
Creditor days41 days
Cash conversion cycle123 days
Working capital days32 days
Leverage
Total debtRs 31 Cr
Cash and bankRs 2 Cr
Net debtRs 29 Cr
Debt to equity1.76x
Net debt / EBITDA6.84x
Interest coverage1.07x
Owners' fund to total sources24.46%
Debt to assets43.11%
Cash flow
Cash from Operating Activity (latest year)Rs 5 Cr
Cash from Investing Activity (latest year)Rs -0 Cr
Cash from Financing Activity (latest year)Rs -8 Cr
Net Cash Flow (latest year)Rs -3 Cr
Free cash flow (latest year)Rs 4 Cr
FCFE (approx.: FCF + change in debt)Rs 2 Cr
Cash from ops / profit, 5 years0.33x
Sales to cash flow27.24x
Statement figures
Net sales (TTM)Rs 126 Cr
Net sales (latest year)Rs 128 Cr
Sales (latest quarter)Rs 33 Cr
Operating profit excl. other income (latest year)Rs 8 Cr
Operating profit (latest quarter)Rs 2 Cr
Other income (TTM)Rs -4 Cr
EBITDA (TTM)Rs 4 Cr
PBDT (TTM)Rs 1 Cr
Profit before tax (TTM)Rs 0 Cr
Tax (latest year)Rs 0 Cr
Net profit (TTM)Rs 0 Cr
Net profit (latest year)Rs 0 Cr
Net profit (latest quarter)Rs 0 Cr
Depreciation (TTM)Rs 1 Cr
Depreciation (latest quarter)Rs 0 Cr
Interest (TTM)Rs 3 Cr
Cost of goods sold (latest year)Rs 113 Cr
Total expenditure (latest year)Rs 119 Cr
Total income (latest year)Rs 124 Cr
Share capitalRs 8 Cr
ReservesRs 10 Cr
Shareholders' fundsRs 18 Cr
Total assetsRs 72 Cr
Net blockRs 8 Cr
InvestmentsRs 0 Cr
ReceivablesRs 22 Cr
InventoryRs 31 Cr
Other liabilitiesRs 23 Cr
Shares outstanding (crore)0.79
Ownership
Promoter holding48.03% (+0.00 in a year)
Computed by MarketFriction from the standalone statements. Returns use average balances.
P/E 283.8 is at the 98th percentile of its own 9.2-year range
(median 23.4, low 9.8, high 290.4).
P/B 2.10 is at the 58th percentile (median 1.72).
Monthly. Market cap from split-adjusted price; profit and book value as reported by that month. A low percentile means cheap versus its own history, not cheap versus peers.
| Period | 530991 | Nifty 50 | Difference |
|---|---|---|---|
| 1 week | +4.2% | -2.8% | +7.0 pts |
| 1 month | -8.0% | -6.8% | -1.2 pts |
| 3 months | -5.3% | -7.6% | +2.3 pts |
| 3 years | +15.6% | +14.2% | +1.5 pts |
| 5 years | +190.4% | +27.9% | +162.5 pts |
Red flags
F-score 7 of 8| explain | Weak cash conversion Cash from operations was 3% of net profit over the last 3 years |
| explain | Receivables outrunning sales Receivables grew 69% vs sales +6% in 2026 |
| explain | Low interest cover Interest cover 1.0x in 2026 |
Checks on the latest reported years: cash vs profit, accruals, receivables and inventory vs sales, dilution, debt, interest cover, equity, other income, losses, and auditor, top-management, insolvency and regulator filings in the last 12 months. A flag asks for an explanation; it is not a verdict.
Latest quarter
Jun 2026Sales ₹33 Cr -5.0% vs Jun 2025.
Net profit ₹0 Cr +17.9%.
Activity
Compare| Company | Mcap (Cr) | P/E | ROCE |
|---|---|---|---|
| Sun Pharmaceutical Industries Ltd | 447,476 | 35.4 | 20.5 % |
| Divis Laboratories Ltd | 250,363 | 84.0 | 22.0 % |
| Torrent Pharmaceuticals Ltd | 186,152 | 83.4 | 15.2 % |
| Zydus Lifesciences Ltd | 119,750 | 24.6 | 21.1 % |
| Cipla Ltd | 111,430 | 31.1 | 15.5 % |
| Laurus Labs Ltd | 106,928 | 97.8 | 17.8 % |
| Mankind Pharma Ltd | 105,120 | 49.3 | 13.5 % |
| Dr Reddys Laboratories Ltd | 104,494 | 32.4 | 13.0 % |
| Aurobindo Pharma Ltd | 97,682 | 25.8 | 12.9 % |
| Lupin Ltd | 93,840 | 15.8 | 29.9 % |
| Glenmark Pharmaceuticals Ltd | 68,905 | 22.1 | 39.8 % |
| Alkem Laboratories Ltd | 62,772 | 27.6 | 21.2 % |
| Biocon Ltd | 61,439 | 84.5 | 3.61 % |
| Abbott India Ltd | 57,949 | 35.9 | 44.8 % |
| Gland Pharma Ltd | 49,333 | 43.1 | 15.1 % |
No bulk or block deals on record.
No corporate actions on record.
No announcements in our files yet.
Company filings to NSE, newest first. Routine notices (trading window, newspaper copies) are left out. Click a row for the filing.
No short selling reported to NSE in our files.
Short sales disclosed by brokers to NSE, by trade date. Collected since late September 2026.
Not on any NSE surveillance list in the latest file.
Quick answers
What is the market cap of Roopa Industries Ltd?
Roopa Industries Ltd (530991) has a market capitalisation of Rs 35.9 Cr. at the 2026-10-01 close.
What is the P/E ratio of Roopa Industries Ltd?
Roopa Industries Ltd trades at a P/E of 8.51 on trailing twelve-month profit, at the 2026-10-01 close.
What were Roopa Industries Ltd's latest quarterly results?
In the Jun 2026 quarter, Roopa Industries Ltd sales was Rs 33 Cr (-5.0% vs Jun 2025) and net profit was Rs 0 Cr.